Abstract, Snapshot, Market Analysis & Market Definition: World Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families.The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs includes 5-HT3 Inhibitors, NK1 Inhibitors and others. The proportion of 5-HT3 Inhibitors in 2017 is about 62%, and the proportion of NK1 Inhibitors in 2017 is about 33%. In 2019, the market size of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs is 77 million US$ and it will reach 115.7 million US$ in 2025, growing at a CAGR of 6.1% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs. This report studies the global market size of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India, and Southeast Asia). This study presents the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019
Market Segmentation, Outlook & Viewpoint: World Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
Segmentation by Product Type: Breakdown of data from the year 2014 to 2019 and forecast until 2025: 5-HT3 Inhibitors
NK1 Inhibitors
Other
Segmentation by Application: Breakdown of data from the year 2014 to 2019 and forecast until 2025:
Highly Emetogenic Chemotherapy
Moderately Emetogenic Chemotherapy
Low Emetogenic Chemotherapy
Other
Top Companies & Key Players: World Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Heron Therapeutics
Roche
Mylan
Tesaro
Key Insights Covered: World Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
1. North America, Europe, Asia Pacific, Middle East & Africa, Latin America market size (sales, revenue, and growth rate) of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs industry.
2. Global major manufacturers' operating situation (sales, revenue, growth rate, and gross margin) of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs industry.
3. Global major countries (United States, Canada, Germany, France, UK, Italy, Russia, Spain, China, Japan, Korea, India, Australia, New Zealand, Southeast Asia, Middle East, Africa, Mexico, Brazil, C. America, Chile, Peru, Colombia) market size (sales, revenue, and growth rate) of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs industry.
4. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs industry.
5. Global market size (sales, revenue) forecast by regions and countries from 2019 to 2024 of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs industry.
Research Methodology: Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
- Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
- Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
- Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.